Dr. Lessnick is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
700 Childrens Dr
Room WA5011
Columbus, OH 43205Phone+1 614-355-2633
Summary
- Dr. Stephen Lessnick is a pediatric hematologist/oncologist in Columbus, OH and is affiliated with Nationwide Children's Hospital. He received his medical degree from David Geffen School of Medicine at UCLA and has been in practice 21 years. He specializes in pediatric sarcoma oncology.
Education & Training
- Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 1989 - 2003
- Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 1996 - 1998
- David Geffen School of Medicine at UCLAClass of 1996
- University of California, Los AngelesPh.D., Molecular Biology, 1994
- Brandeis UniversityB.A., Biochemistry and Biology, Cum Laude, 1989
Certifications & Licensure
- OH State Medical License 2015 - 2026
- UT State Medical License 2004 - 2016
- MA State Medical License 1998 - 2005
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Elizabeth M. & Richard M. Ross Endowed Chair in Pediatric Research Nationwide Children’s Hospital, 2015
- Department of Pediatrics “Catalyst” Investigator Award University of Utah, 2013
- Jon and Karen Huntsman Presidential Professor in Cancer Research (equivalent to an endowed chair) University of Utah, 2009
- Join now to see all
Clinical Trials
- Study of Tumor Samples From Patients With Ewing Sarcoma Start of enrollment: 2008 Sep 01
- Collecting and Storing Biological Samples From Patients With Ewing Sarcoma Start of enrollment: 2008 Feb 04
- Biomarkers in Tissue Samples From Patients With Ewing Sarcoma Start of enrollment: 2011 Dec 01
Publications & Presentations
PubMed
- DBD-α4 helix of EWSR1::FLI1 is required for GGAA microsatellite binding that underlies genome regulation in Ewing sarcoma.Ariunaa Bayanjargal, Cenny Taslim, Iftekhar A Showpnil, Julia Selich-Anderson, Jesse C Crow
Biorxiv. 2024-06-07 - 19 citationsRandomized Phase III Trial of Ganitumab With Interval-Compressed Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma: A Report From the Children's ...Steven G DuBois, Mark D Krailo, Julia Glade-Bender, Allen Buxton, Nadia Laack
Journal of Clinical Oncology. 2023-04-10 - 15 citationsThe ETS transcription factor ETV6 constrains the transcriptional activity of EWS-FLI to promote Ewing sarcoma.Diana Y Lu, Jana M Ellegast, Kenneth N Ross, Clare F Malone, Shan Lin
Nature Cell Biology. 2023-02-01
Journal Articles
- Author Correction: EWS–FLI1 Increases Transcription to Cause R-loops and Block BRCA1 Repair in Ewing SarcomaKimberly Stegmaier, Stephen L Lessnick, Jeffrey A Toretsky, Nature
- Comparison of Clinical Features and Outcomes in Patients with Extraskeletal Versus Skeletal Localized Ewing Sarcoma: A Report from the Children’s Oncology GroupCash, T, McIlvaine, E, Krailo, MD, Lessnick, SL, Lawlor, ER, Laack, N, Sorger, J, Marina, N, Grier, HE, Granowetter, L, Womer, RB, and Dubois SG, Pediatr Blood Cancer, 1/1/2016
- Recent advances in targeted therapy for Ewing sarcomaPishas, KI and Lessnick, SL, F1000Research, 1/1/2016
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Epigenomic profiling reveals global reorganization of the chromatin regulatory network in Ewing sarcoma.Saund, R, Lessnick SL, Cell Symposia- Biology and Data Science, Berkeley, CA, 1/1/2016
- EWS/FLI Hijacks Chromatin Regulatory Complexes to Maintain Malignancy in Ewing Sarcoma Cells.Theisen ER, Lessnick SL, Connective Tissue Oncology Society annual meeting, Lisbon, Portugal, 1/1/2016
- Defining the mechanisms of sensitivity to HCI-2509: A novel LSD1 inhibitor for the treatment of Ewing sarcoma.Pishas, KI, Sharma, S, Lessnick, SL, Connective Tissue Oncology Society annual meeting, Lisbon, Portugal, 1/1/2016
- Join now to see all
Lectures
- Targeting Translocations in Pediatric Leukemias and SarcomasRockville, MD - 1/1/2015
- Topical Advances and Applications in Bone PathologySan Diego, CA - 1/1/2014
- Molecular Biology and Innovative Therapies in Sarcomas of Childhood and AdolescencePultusk, Poland - 1/1/2012
- Join now to see all
Other
- Epidemiology, pathology, and molecular genetics of the Ewing sarcoma family of tumors.Delaney, T, Hornicek, F, Lessnick, SL, and Mankin H; Basow, DS (Ed), UpToDate
Waltham, MA - 1/1/2010 - Epidemiology, pathology, and molecular genetics of the Ewing sarcoma family of tumorsLessnick SL, Hornicek FJ, Mankin HJ, DeLaney TF
http://www.uptodate.com/contents/epidemiology-pathology-and-molecular-genetics-of-the-ewing-sarcoma-
UpToDate, Wolters Kluwer Health - 2012-04-23
Press Mentions
- Two Classes of GGAA-Microsatellites in a Ewing Sarcoma ContextNovember 1st, 2017
- Cruel Fusion: What a Young Man’s Death Means for Childhood CancerMarch 28th, 2017
- Possible New Treatment for Ewing SarcomaNovember 26th, 2012
- Join now to see all
Grant Support
- EWS/FLI And Its Targets In Ewing'S SarcomaNational Cancer Institute2010–2012
- Antibody-Based Detection Of Translocations In Pediatric CancerNational Cancer Institute2009–2011
- Tumor Suppressors In Ewing'S SarcomaNational Cancer Institute2004–2007
- Tumor Suppressors In Ewing'S SarcomaNational Cancer Institute2002–2004
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: